InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: A deleted message

Monday, 06/13/2011 1:16:54 PM

Monday, June 13, 2011 1:16:54 PM

Post# of 187
Vertex Pharmaceuticals (VRTX) and Alios BioPharma announced an exclusive worldwide licensing agreement that will add two distinct nucleotide analogues to Vertex's hepatitis C portfolio.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VRTX News